Pre-transplant Alpha Fetoprotein is Associated with Post-transplant Hepatocellular Carcinoma Recurrence Mortality.

08:00 EDT 8th June 2019 | BioPortfolio

Summary of "Pre-transplant Alpha Fetoprotein is Associated with Post-transplant Hepatocellular Carcinoma Recurrence Mortality."

Although liver transplantation may potentially cure hepatocellular carcinoma (HCC), the risk of HCC recurrence is 8-20% at five years post-transplant. Pre-transplant alpha fetoprotein (AFP) is a predictor of HCC recurrence, but it is unknown if pre-transplant AFP also predicts survival in patients with recurrence.


Journal Details

This article was published in the following journal.

Name: Clinical transplantation
ISSN: 1399-0012
Pages: e13634


DeepDyve research library

PubMed Articles [8348 Associated PubMed Articles listed on BioPortfolio]

Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.

Mixed evidence challenges preoperative alpha-fetoprotein (AFP) as an independent prognostic factor for patients with hepatocellular carcinoma (HCC) after hepatectomy.

Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma: A meta-analysis.

Post-treatment alpha-fetoprotein (AFP) response has been reported to be associated with prognosis of hepatocellular carcinoma (HCC) patients, but the results were not consistent. This meta-analysis ai...

Vitamin D deficiency is common in kidney transplant recipients, but is not associated with infections after transplantation.

The relevance of vitamin D for infections after kidney transplantation is poorly defined. 25-OH vitamin D (25-OHD) levels of 135 kidney transplant recipients, enrolled in the Swiss Transplant Cohort S...

Post-transplant diabetes mellitus associated with heart and lung transplant.

The incidence of post-transplant diabetes (PTDM) is variable primarily due to a lack of standardised diagnostic criteria.

The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.

Hepatocellular carcinoma (HCC) has become a pressing health problem facing the world today due to its high morbidity, high mortality, and late discovery. As a diagnostic criteria of HCC, the exact thr...

Clinical Trials [8951 Associated Clinical Trials listed on BioPortfolio]

Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response

The secretion by tumor cells of alpha fetoprotein (AFP) was observed in 50 to 60% of hepatocellular carcinoma. The AFP can be used as a marker for tumor recurrence after treatment and may ...

ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma

Clinical study to evaluate safety (primary objectives) and efficacy (secondary objective) of ET1402L1-ARTEMIS™2 T cells in patients with alpha fetoprotein positive (AFP+ ) hepatocellular ...

Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

During transplant surgery, there is a period of time when a donated kidney is removed from a donor's body and stored until the time of the transplant surgery. The storage procedure result...

Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients

This Phase I study of sorafenib in high risk hepatocellular cancer patients after liver transplantation will study 24 subjects for about 5 years. Each subject will receive sorafenib for 6 ...

Aralast NP in Islet Transplant

Islet transplantation is a relatively new procedure used in people with difficult to control Type 1 diabetes. Insulin producing cells (islets) are isolated from a pancreas donated by the n...

Medical and Biotech [MESH] Definitions

Providers of tissues for transplant to non-related individuals.

The body location or part from which tissue is taken for TRANSPLANTATION.

Transplant comprised of an individual's own tissue, transferred from one part of the body to another.

An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient.

Non-cadaveric providers of organs for transplant to related or non-related recipients.

Quick Search

DeepDyve research library

Relevant Topic

Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Searches Linking to this Article